Check Cap Ltd (NASDAQ:CHEK) — Market Cap & Net Worth
Market Cap & Net Worth: Check Cap Ltd (CHEK)
Check Cap Ltd (NASDAQ:CHEK) has a market capitalization of $9.42 Million ($9.42 Million) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27025 globally and #5366 in its home market, demonstrating a -2.80% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Check Cap Ltd's stock price $139.00 by its total outstanding shares 5850906 (5.85 Million). Analyse CHEK operating cash flow to see how efficiently the company converts income to cash.
Check Cap Ltd Market Cap History: 2015 to 2026
Check Cap Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.65 Billion to $813.28 Million (-14.68% CAGR).
Index Memberships
Check Cap Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.00% | #783 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #2555 of 3165 |
Weight: Check Cap Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Check Cap Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Check Cap Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
13524.23x
Check Cap Ltd's market cap is 13524.23 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.30 Billion | $244.00K | -$8.83 Million | 13524.23x | N/A |
Competitor Companies of CHEK by Market Capitalization
Companies near Check Cap Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Check Cap Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Check Cap Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Check Cap Ltd's market cap moved from $2.65 Billion to $ 813.28 Million, with a yearly change of -14.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $813.28 Million | +8223.35% |
| 2025 | $9.77 Million | +68.70% |
| 2024 | $5.79 Million | -52.41% |
| 2023 | $12.17 Million | -5.45% |
| 2022 | $12.87 Million | -83.70% |
| 2021 | $78.99 Million | +46.74% |
| 2020 | $53.83 Million | -73.26% |
| 2019 | $201.27 Million | -20.00% |
| 2018 | $251.59 Million | -79.41% |
| 2017 | $1.22 Billion | -62.98% |
| 2016 | $3.30 Billion | +24.34% |
| 2015 | $2.65 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Check Cap Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.42 Million USD |
| MoneyControl | $9.42 Million USD |
| MarketWatch | $9.42 Million USD |
| marketcap.company | $9.42 Million USD |
| Reuters | $9.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Check Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.